Skip to main content
. 2019 Jun 28;104(10):4931–4940. doi: 10.1210/jc.2019-00926

Table 1.

Clinical Characteristics and Oxytocin Parameters of the Study Participants (n = 67)

Variables All Participants
Age, y 22.4 ± 0.9
BMI z score (<20 y, n = 28) −1.3 ± 0.1
BMI (≥20 y, n = 39), kg/m2 17.9 ± 0.2
Expected body weight, % 85.4 ± 1.3
Restricting/binge-purge behavior, n (%) 53 (79)/14 (21)
Premenarchal, n (%) 3 (4.5)
Lower estrogen status, n (%)a 43 (64.2)
Higher estrogen status, n (%) 24 (35.8)
Kilocalories consumed 376.9 ± 9.9
EDE global score 3.0 ± 0.2
Oxytocin parameters
 OT T0, pg/mL 1024.6 ± 55.4
 OT T30 pg/mL 999.6 ± 51.0
 Difference in OT from T0 to T30, pg/mL −24.9 ± 28.4
 OT T60, pg/mL 919.5 ± 45.8
 Difference in OT from T0 to T60 (pg/mL) −105.1 ± 32.6 (0.002)b
 OT T120, pg/mL 940.2 ± 48.7
 Difference in OT from T0 to T120 (pg/mL) −84.4 ± 28.9 (0.005)b
 OT nadir, pg/mL 820.4 ± 42.6
 Difference in OT from T0 to nadir (pg/mL) −204.3 ± 24.7 (<0.001)b
 Change in OT from T0 to nadir, % −17.8 ± 1.9

Data are reported as mean ± SEM.

Abbreviations: T0, time 0 (fasting); T30, time 30 min following the meal; T60, time 60 min following the meal; T120, time 120 min following the meal.

a

Lower estrogen status includes females who are in the early to mid-follicular phase of the menstrual cycle, amenorrheic, or premenarcheal.

b

P value compared with baseline oxytocin (paired t test).